The bill amends Iowa law to create a regulatory framework for the production and administration of psilocybin, a psychoactive compound found in certain mushrooms. It introduces a new section, 124F, which defines key terms related to psilocybin, such as "active psilocybin" and "qualified medical psilocybin provider." The legislation allows individuals to recommend, possess, and administer psilocybin under the guidelines of chapter 124F and establishes a licensing board to oversee psilocybin production facilities and testing laboratories. The bill mandates strict inventory control systems, operational guidelines, and safety protocols, including real-time tracking and video recording of psilocybin handling, while also prohibiting the establishment of production facilities near community or residential areas.

Additionally, the bill outlines requirements for the registration and continuing education of qualified medical psilocybin providers, ensuring thorough patient assessments before recommending psilocybin. It includes provisions to protect employees using medical psilocybin from discrimination and clarifies that psilocybin use does not disqualify individuals from receiving necessary medical care. The legislation also establishes penalties for unauthorized access to patient information and mandates annual reports to the General Assembly on psilocybin use statistics. Overall, the bill aims to create a structured and regulated environment for psilocybin use in therapeutic settings while ensuring public safety and compliance with state laws.

Statutes affected:
Introduced: 124.401
Reprinted: 124.401